Search Within

Renier J Brentjens

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (8)
  3. Review (1)
Groups
  1. Adult Leukemia (21)
  2. Center for Hematologic Malignancies (21)
  3. Center for Molecular Imaging and Biotechnology (21)
  4. Department of Medicine (21)
  5. GSK Faculty (21)
  6. Hematologic Malignancies Research (21)

More Groups

People
  1. David Scheinberg (12)
  2. Nancy Kernan (8)
  3. Richard O'Reilly (8)
  4. Kevin Curran (7)
  5. Isabelle Riviere (6)
  6. Joseph Jurcic (6)

More People

Years
  1. 2022 (1)
  2. 2020 (4)
  3. 2019 (2)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (2)

More Years

Publications
  1. Blood (8)
  2. Bone Marrow Transplantation (2)
  3. Journal of Clinical Oncology (2)
  4. Molecular Therapy (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Nature Publishing Group (5)
  3. American Association for Cancer Research (2)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Inc. (1)
  6. MDPI (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Engineering CAR-T cells to activate small-molecule drugs in situ
    Journal Article

    Gardner, T. J.; Lee, J. P.; Bourne, C. M.; Wijewarnasuriya, D.; Kinarivala, N.; Kurtz, K. G.; Corless, B. C.; Dacek, M. M.; Chang, A. Y.; Mo, G.; more...
    Nature Chemical Biology (2022)

    Fulltext@MSK | Save
  • Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
    Journal Article

    Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Targeted cellular micropharmacies: Cells engineered for localized drug delivery
    Review

    Gardner, T. J.; Bourne, C. M.; Dacek, M. M.; Kurtz, K.; Malviya, M.; Peraro, L.; Silberman, P. C.; Vogt, K. C.; Unti, M. J.; Brentjens, R.; more...
    Cancers (2020)

    Fulltext@MSK | Save
  • Targetable micropharmacies: Cells that produce small-molecule drugs in situ at the tumor site
    Meeting Abstract

    Gardner, T. J.; Lee, P.; Wijewarnasuriya, D.; Kinarivala, N.; Bourne, C.; Kurtz, K.; Corless, B.; Dacek, M.; Mo, G.; Brentjens, R.; more...
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Optimization of T-cell receptor-modified T cells for cancer therapy
    Journal Article

    Drakes, D. J.; Rafiq, S.; Purdon, T. J.; Lopez, A. V.; Chandran, S. S.; Klebanoff, C. A.; Brentjens, R. J.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Engineering armored T cell receptor-mimic (TCRm) chimeric antigen receptor (CAR) T cells specific for the intracellular protein Wilms tumor 1 (WT1) for treatment of hematologic and solid malignancies
    Meeting Abstract

    Rafiq, S.; Purdon, T.; Dao, T.; Liu, C.; Scheinberg, D.; Brentjens, R. J.
    Molecular Therapy (2016)

    Fulltext@MSK | Save